SOURCE-LINKED STUDY SUMMARY
Strengthening muscle for healthy ageing: innovative treatments for sarcopenia.
Abstract summarizedQuality not appraised
- What was studied
- An overview discussed experimental treatments for sarcopenia, the age-related loss of muscle mass and strength.
- Who / model studied
- The article discusses ageing-related muscle loss. No specific participant cohort, sample size or follow-up period is described in the abstract.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- It outlines approaches involving NAD-related compounds, urolithin A, myostatin inhibition and other targets. It also notes trials combining GLP-1 weight-loss medicines with potential muscle-preserving treatments. No numerical strength, muscle-mass or longevity outcomes are reported.
- Limitations & context
- Study limitations were not stated in the abstract. Methodological quality has not been appraised.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1038/s41573-026-01514-3